Bioactive fragments of complement, such as C3a, C4a and C5a, are released during the course of complement activation and are called anaphylatoxins, which cause anaphylactic shock when produced in large amounts and increase vascular permeability. The gene discussed is C4A; the disease is anaphylaxis.